NEW YORK, Feb. 26, 2026 /PRNewswire/ -- Belfry Software, a modern platform for physical security providers, has partnered with Willis, a WTW business (NASDAQ: WTW), to launch a digital insurance program tailored for Belfry customers. The program pairs Willis insurance expertise with award-winning Kayna insurance technology to deliver data-led, streamlined insurance solutions. ...

PresentationRobert BorinChief Executive Officer Good morning, everyone, and welcome to Cavendish Hydrogen's Q4 presentation. My name is Robert Borin, and I am the CEO of Cavendish Hydrogen. And with me today, I have our CFO, Marcus Halland. The presentation this morning will take approximately 20 minutes, and there will be a live Q&A session after the presentation. Most of you know us pretty well by now. But for those of you who are new to our company, I will start with a short introduction before I move on ...

It may have escaped the attention of investors focused on gold and silver over the past year, but tungsten has become one of the most in-demand metals in global commodity markets. The driver is defence. Tungsten’s combination of extreme density, hardness, and a very high melting point makes it essential for weapons, armour, and shielding, as well as for aerospace and other high-end applications. Prices doubled in 2025 as defence demand accelerated and China announced new export controls. Tungsten ammonium p ...

INNOVATION WAVE HAS SOMETHING LIKE IT. >> YOU'RE SAYING IT'S AN AI. >> WELL, I DON'T I DON'T SEE WHAT IS THE WHAT IS THE ALTERNATIVE.>> THERE IS NO ALTERNATIVE. THAT'S THE DEFENSE. >> IF YOU'RE IN THE BUSINESS, YOU'RE IN THE BUSINESS.>> YEAH. >> CAN WE TALK ABOUT SOFTWARE WHICH IS TRYING TO MAKE A BIT OF A TURN TODAY. SOME, YOU KNOW, LOOKING AT THE PRICE ACTION AND SOME OF THOSE NAMES AND SAYING, WELL, MAYBE WE'RE TRYING TO PUT A BOTTOM IN.IF YOU LOOK AT SALESFORCE WAS DOWN, LET'S LOOK AT SALESFORCE BECAUSE ...

Key Takeaways Snowflake beat Q4 earnings and revenue estimates with 30% sales growth, but shares dipped after hours. SNOW posted 125% net revenue retention and 21% customer growth to 13,328, with RPO up 42%. Snowflake guides for 27% product revenue growth in Q1 and FY2026, targeting 12.5% operating margin. Snowflake (SNOW) reported fourth-quarter fiscal 2026 non-GAAP earnings of 32 cents per share, beating the Zacks Consensus Estimate by 19.18%. The company reported earnings of 30 cents per share in the yea ...

Key Takeaways Photronics Q1 EPS rose 17% Y/Y to 61 cents, beating estimates as revenue increased 6%.PLAB IC sales grew 7% Y/Y on high-end demand; FPD gained on China IT market strength.Photronics guided Q2 revenue of $212M-$220M with operating margin seen at 22%-24%.Photronics (PLAB) reported first-quarter fiscal 2026 non-GAAP earnings of 61 cents per share, which beat the Zacks Consensus Estimate by 12.96% and increased 17.3% year over year.Revenues of $225.1 million increased 6.1% year over year and 4.3% ...

Key Takeaways Agilent reported Q1 EPS of $1.36, up Y/Y, while revenues rose 7% to $1.8 billion. Agilent saw revenue growth across LDG, ACG, and AMG, but segment margins declined Y/Y. Agilent guided Q2 revenues of $1.79-$1.82B and FY26 sales of $7.3-$7.5B. Agilent Technologies (A) reported first-quarter fiscal 2025 earnings of $1.36 per share, which missed the Zacks Consensus Estimate by 0.52%. The figure increased 3.8% year over year.Revenues of $1.8 billion surpassed the Zacks Consensus Estimate by 0.27%. ...

Willis Lease Finance Corporation (WLFC) shares have climbed 35.3% in the past six months compared with the industry’s 21.8% growth. The company has outperformed other industry players, including Air Lease Corporation (AL) and Ryder System, Inc. (R) . Shares of AL and R have gained 7.2% and 18%, respectively, in the same time frame. Sustained aviation supply-demand imbalances, firm lease rates, institutional capital partnerships, in-house technical capabilities and long-term service agreements drive recurrin ...

United Therapeutics Corp (NASDAQ:UTHR) reported better-than-expected earnings for the fourth quarter on Wednesday.The company posted quarterly earnings of $7.70 per share which beat the analyst consensus estimate of $7.09 per share. The company reported quarterly sales of $790.200 million which missed the analyst consensus estimate of $813.077 million.“As we close out another remarkable year with record total revenue for the fourth year in a row, I extend my thanks to our Unitherians whose unwavering commit ...

United Therapeutics Corp (NASDAQ:UTHR) reported better-than-expected earnings for the fourth quarter on Wednesday.The company posted quarterly earnings of $7.70 per share which beat the analyst consensus estimate of $7.09 per share. The company reported quarterly sales of $790.200 million which missed the analyst consensus estimate of $813.077 million.“As we close out another remarkable year with record total revenue for the fourth year in a row, I extend my thanks to our Unitherians whose unwavering commit ...